Objectives-To compare the sensitivities of individual and combined sonography of hyperechoic aggregates and the double-contour sign in detecting monosodium urate (MSU) crystal deposits in gouty joints.
G
out is a disorder of uric acid metabolism, usually associated with hyperuricemia, which causes inflammatory arthropathy due to deposition of monosodium urate (MSU) crystals in joints and soft tissues. 1 If not treated appropriately, the MSU deposits can ultimately cause joint destruction as well as multiorgan dysfunction, including the kidney and heart. 2, 3 Moreover, an acute attack of gouty arthritis ranks among the most painful experiences reported throughout medical history. [4] [5] [6] Early and accurate diagnosis is, therefore, critical for immediate and appropriate treatment of gout.
Gout is typically diagnosed clinically on the basis of the rapid development of monoarticular arthritis, usually involving the first metatarsophalangeal joint. [4] [5] [6] For typical presentations of gout, a clinical diagnosis alone is reasonably accurate but is not definitive without confirmation of MSU crystal deposits. The presence of MSU crystals in synovial fluid or tophus aspirates is considered the reference standard for diagnosis of gout. 7 However, aspiration of synovial fluid may not be straightforward, and joint radiographic findings may be normal. [4] [5] [6] Thus, noninvasive imaging technologies to accurately detect MSU crystals within joints and periarticular soft tissue would be desirable for gout diagnosis and treatment.
Conventional radiography can be used to confirm suspected gout, but with limited sensitivity, and it is typically only capable of detecting late-stage gout. 8, 9 The use of high-frequency sonography, dual-energy computed tomography (CT), and magnetic resonance imaging can reveal findings indicative of gout, even early in gout pathogenesis, thereby securing a role in the early diagnosis and management of gout. However, magnetic resonance imaging is expensive and has poor specificity 9 ; dual-energy CT enables simultaneous direct visualization of MSU crystal deposits and bone structures and is, thus, sensitive, noninvasive, and reproducible for gout diagnosis. 10, 11 The high costs and necessity of a special scanning machine, however, may limit dual-energy CT use.
Sonography provides high-resolution imaging capable of detecting and identifying pathognomonic MSU crystal deposits in gouty joints and periarticular regions as well as adjacent synovitis and joint effusion. [12] [13] [14] Moreover, sonography has advantages of machine portability, low cost, and absence of ionizing radiation, making it preferable for early diagnosis and even for monitoring the treatment response in gout. [12] [13] [14] [15] The double-contour sign and hyperechoic aggregates are the most common findings on sonography of MSU crystal deposits in gouty joints. 16 The double-contour sign is generally considered a sensitive finding characteristic of gout, and the American College of Rheumatologists gout diagnosis guidelines recommend the use of the doublecontour sign for scoring severity in gout. 9, 12, 13, 17 Reports in the literature, however, are controversial with regard to the sensitivity and specificity of hyperechoic aggregates in diagnosing gout. 8, 9, 18 Furthermore, it is inconclusive whether the detection frequencies of the double-contour sign and hyperechoic aggregates vary substantially in different joints. A single report suggested that hyperechoic aggregates were detected more frequently in upper extremity joints, whereas the detection frequencies of the double-contour sign and hyperechoic aggregates in lower extremity joints were similar in patients with gout. 19 Assessment of gouty joints on sonography of multiple parts of limbs (a total of 6 parts in both upper and lower limbs) was reported. The radiocarpal joint, patellar tendon, and triceps tendon were characterized by hyperechoic aggregates; the first metatarsophalangeal joint, talus, and second metatarsophalangeal joint were characterized by the double-contour sign. Such investigations are often not feasible in resource-constrained settings. In our study, we only examined the acute joint and its counterpart in the contralateral limb and assessed the sonographic images of hyperechoic aggregates and the double-contour sign simultaneously. We observed relatively high sensitivity of this method for diagnosis of gout in this study. Another innovation of this study was that we evaluated the sensitivity of the double-contour sign and hyperechoic aggregates, both individually and in combination, for diagnosis of gout in upper and lower limbs.
In this study, we reviewed 6971 patients with gout, and 70 patients were included in the study. We evaluated the sensitivity and specificity of sonography for detection of MSU deposits: ie, the diagnostic efficacy of the double-contour sign and hyperechoic aggregates for diagnosis of gout in suspected patients. The results suggest that the combined use of imaging findings of the double-contour sign and hyperechoic aggregates may help detect MSU in suspected cases.
The primary objective was to evaluate the sensitivity and specificity of hyperechoic aggregates in diagnosing gout when used in combination with the doublecontour sign, which has established sensitivity and specificity in the diagnosis of gout. The secondary objectives were to assess whether the detection frequencies of the double-contour sign and hyperechoic aggregates varied significantly in different joints and to compare the double-contour sign and hyperechoic aggregate findings between symptomatic and asymptomatic joints.
Materials and Methods

Patients
We reviewed all 6971 patients with gout (inpatient, 2025; outpatient, 4946) between January 1, 2012, and December 31, 2015, in the Second Affiliated Hospital of Zhejiang University School of Medicine. All patients who met the acute gout inclusion criteria were eventually hospitalized because of acute arthritis. The inclusion criteria were as follows (1) age of 18 years or older; (2) patients who fulfilled preliminary criteria for the classification of acute arthritis from primary gout; (3) previous depictions of MSU crystals in synovial fluid or tophus aspirates; (4) dual-energy CT screening of both the symptomatic and the contralateral asymptomatic joint and detection of MSU crystal deposits in the symptomatic joint; (5) sonography conducted within 1 week of dual-energy CT; (6) no intra-articular injections of steroids in the study joints for 3 months before the study; and (7) 21 ), infectious arthritis, psoriasis, cancers, or severe renal disease (estimated glomerular filtration rate <30 mL/min). This study was approved by the Institutional Review Board, and all patients provided written informed consent before study participation.
Dual-Energy CT Examinations
A dual-energy CT scanner (Siemens Healthcare, Erlangen, Germany) was programmed as follows for joint scanning: tube A (140 kV peak ; 70 mA) and tube B (80 kV 0 ; detector collimation, 64 3 0.6 mm; rotation time, 0.5 seconds per cycle). Transverse sections were reconstructed from the dual-energy data sets with a slice thickness of 1 mm and an increment of 0.7 mm. Data sets from both tubes were loaded onto and reconstructed with a commercially available software program (Synogo Dual Energy; Siemens Healthcare). This software uses automatic color-coding visualization to detect uric acid crystals.
Sonographic Examinations
Sonographic examinations were performed within 7 days of the dual-energy CT scans with a MyLab30 VET system (Esaote SpA, Milan, Italy) equipped with transducers of 10 to 18 MHz for upper limb and 4 to 10 MHz for lower limb joints to acquire grayscale images.
Two specialists (1 radiologist and 1 rheumatologist) independently read the dual-energy CT and sonographic images. Only the images recognized as positive by both specialists were marked as being MSU deposit-positive.
Statistical Analyses
All statistical analyses were conducted with SAS 9.3 software (SAS Inc, Cary, NC). Two-tailed tests were conducted for sample comparisons, and P < .05 was considered indicative of statistical significance. Agreement of the corresponding diagnoses between the specialists was measured by the Cohen j coefficient.
Results
We evaluated 195 symptomatic joints and an equal number of asymptomatic joints on the corresponding contralateral side in 70 patients with acute gout (Table  1) . Sonography detected MSU deposits (double-contour sign, hyperechoic aggregates, or both) in 181 (92.82%) of the symptomatic joints and 74 (37.95%) of the asymptomatic joints. The detection rate of MSU in the symptomatic joints was significantly higher than in the asymptomatic joints (v 2 5129.7054; P < .0001). were double-contour sign/hyperechoic aggregate positive. The 9 patients with symptomatic joints in both the upper and lower limbs were 100% positive for both the double-contour sign and hyperechoic aggregates.
The coefficients for diagnostic outcomes between the specialists were j 5 0.995 (95% confidence interval, 0.9853-1.0000) for the double-contour sign and j 5 0.9743 (95% confidence interval, 0.9519-1.9967) for hyperechoic aggregates.
Discussion
First, our results confirmed that sonography can sensitively and specifically detect MSU deposits in patients with acute gout. More important, we found that combining the double-contour sign and hyperechoic aggregates on sonography results in greater sensitivity and specificity than the double-contour sign or hyperechoic aggregates individually in detecting MSU deposits in joints. These results strongly suggest that combined sonography using both the double-contour sign and hyperechoic aggregates may be used primarily to detect MSU deposits for accurate diagnosis of gout.
Furthermore, we found that hyperechoic aggregates were more frequently seen than the double-contour sign in the joints of the upper limb, whereas the doublecontour sign was more frequently detected in the lower limb. Our results suggest that MSU deposition dynamics may vary in the joints of the upper and lower limbs. These differences in the MSU deposition dynamics may be attributable to the differences in their structures and the weights they bear. Monosodium urate crystals predominantly deposit in the superficial portions of the articular cartilage and appear as an irregular hyperechoic line over the anechoic cartilage, together with another hyperechoic line of the subchondral bone, presenting the characteristic double-contour sign on sonography (Figure 1) . 12 The MSU crystal tophi in joints appear as inhomogeneous (hypoechoic and hyperechoic) aggregates surrounded by a small anechoic rim on sonography, presenting the other characteristic of hyperechoic aggregates in gout (Figure 2) . 12, 16 The distribution of MSU crystals, which are subject to articular movement and the consequent pressure, may tend to move toward and deposit in the surrounding soft tissues or into a large space. 22 Monosodium urate deposits in the upper limb joints with their "smaller" articular cavity may more likely be "pushed" toward the joint perimeter to aggregate into tophi, which are thus detected as hyperechoic aggregates. However, the MSU deposits in the lower limb joints with their "larger" articular cavity may more readily deposit onto the cartilage surfaces and are, therefore, detected as the double-contour sign on sonography.
We also detected MSU crystal deposits in some asymptomatic joints by the appearance of both the double-contour sign and hyperechoic aggregates, although at frequencies significantly lower than in the symptomatic joints. Although we could not completely exclude false-positive sonographic findings, considering that these "asymptomatic joints" are in fact tissues in patients with acute gout, these results may indicate "subclinical or hidden gout," as previously reported. 23 A comprehensive investigation of normal joints in a large cohort of healthy participants will be needed to substantially minimize false-positive MSU sonographic findings in the future.
We also would like to point out some weaknesses in this study: (1) All patients analyzed were inpatients, who may have had more severe arthritis in a more joints than the general population of patients with gout such as outpatients, and this factor may have contributed to a selection bias. (2) The joints evaluated do not cover all types of joints in either the upper or lower limbs. Therefore, readers should cautiously take these factors into account for accurately interpreting our data. (3) With respect to lower limb joints, our findings differ from those reported in a previous study. 19 The difference was likely attributable to differences in the characteristics of the enrolled patients. The previous study included patients with chronic gout without acute exacerbation. In our study, patients with acute exacerbation of gout were included. The bias in patient selection and the small sample sizes may also account for the inconsistency in results between the studies. (4) It is pertinent to mention that the methods used in this study are within the accepted norms for radiologic and rheumatologic assessments in general. However, there are other methods that may be useful as well. For instance, simple x-ray findings in comparison with sonographic and CT findings would also be informative and have higher specificity. 8 In summary, our data show that sonography combining the double-contour sign and hyperechoic aggregates is more sensitive than the double-contour sign or hyperechoic aggregates alone for detecting MSU deposits. Furthermore, our results contribute toward a resolution of certain inconclusive (even controversial) issues critical to the use of sonography for the diagnosis and management of gout. 8, 9, 18 
